Iksuda Therapeutics: Funding, Investors & Team (Oct 2026)
Iksuda Therapeutics (Iksuda) is the developer of a new generation antibody drug conjugates (ADCs).
Iksuda Therapeutics has raised $48.2M across 1 funding round on record, the most recent an undisclosed round of $48.2M announced in Jun 2021.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Iksuda Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2021.
Iksuda Therapeutics Funding Rounds
Iksuda Therapeutics Founders and Leadership Team
Contact details for the Iksuda Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Iksuda Therapeutics Funding Compared to Other Biotechnology Startups
Iksuda Therapeutics' latest round of $48.2M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Iksuda Therapeutics in Biotechnology and Newcastle Upon Tyne
Companies Similar to Iksuda Therapeutics
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Iksuda Therapeutics Funding FAQs
What does Iksuda Therapeutics do?
Iksuda Therapeutics (Iksuda) is the developer of a new generation antibody drug conjugates (ADCs).
How much funding has Iksuda Therapeutics raised?
Iksuda Therapeutics has raised $48.2M across 1 round on record. The most recent is an undisclosed round of $48.2M announced in Jun 2021.
When did Iksuda Therapeutics last raise funding?
Iksuda Therapeutics' most recent funding round on record is an undisclosed round of $48.2M, announced in Jun 2021.
Who is the CEO of Iksuda Therapeutics?
David Simpson is listed as CEO at Iksuda Therapeutics.
Where is Iksuda Therapeutics headquartered?
Iksuda Therapeutics is based in Newcastle Upon Tyne, United Kingdom.
How many employees does Iksuda Therapeutics have?
Iksuda Therapeutics is in the 11-50 employee band.
How does Iksuda Therapeutics' funding compare to other Biotechnology startups?
Iksuda Therapeutics' latest round of $48.2M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Iksuda Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Iksuda Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.